Back to Journals » Drug Design, Development and Therapy » Volume 10

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)

Total article views   Abstract views HTML views PDF downloads Totals
9,255 Dovepress* 6,474 1,346+ 1,260 7,820
PubMed Central* 0 1,435 546 1,435
Totals 6,474 2,781 1,806 9,255
*Since 16 August 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar